Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone Marrow …, 2016 - nature.com
Reduced-intensity conditioning (RIC) has offered many primary immunodeficiency disorder
(PID) patients who are ineligible for myeloablative regimens a chance of cure. However, the …

Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone Marrow …, 2015 - europepmc.org
Reduced-intensity conditioning (RIC) has offered many primary immunodeficiency disorder
(PID) patients who are ineligible for myeloablative regimens a chance of cure. However, the …

Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone marrow …, 2016 - pubmed.ncbi.nlm.nih.gov
Reduced-intensity conditioning (RIC) has offered many primary immunodeficiency disorder
(PID) patients who are ineligible for myeloablative regimens a chance of cure. However, the …

[引用][C] Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone Marrow …, 2015 - cir.nii.ac.jp
Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity
conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with …

Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone Marrow …, 2016 - go.gale.com
Reduced-intensity conditioning (RIC) has offered many primary immunodeficiency disorder
(PID) patients who are ineligible for myeloablative regimens a chance of cure. However, the …

[引用][C] Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell …

AA Hamidieh, M Behfar, Z Pourpak… - Bone Marrow …, 2016 - Nature Publishing Group